SEC Filing: Form 8-K Current report Post date July 30, 2025 Post categories In Uncategorized Filed: 2025-07-30 00:00:00 Filing Summary: Filing Summary Filing Details: SEC Filing Detail Post navigation ←Previous post:VYNE Investor Relations Presentation→Next post:VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo
VYNE Therapeutics
VYNE Therapeutics